Issue 1/2018
Content (22 Articles)
PET-guided clinical trials in Hodgkin lymphoma: to agree or not to agree, that is the reviewer’s question
A. Gallamini, M. Meignan
Clinical impact of PSMA-based 18F–DCFBC PET/CT imaging in patients with biochemically recurrent prostate cancer after primary local therapy
Esther Mena, Maria L. Lindenberg, Joanna H. Shih, Stephen Adler, Stephanie Harmon, Ethan Bergvall, Deborah Citrin, William Dahut, Anita T. Ton, Yolanda McKinney, Juanita Weaver, Philip Eclarinal, Alicia Forest, George Afari, Sibaprasad Bhattacharyya, Ronnie C. Mease, Maria J. Merino, Peter Pinto, Bradford J. Wood, Paula Jacobs, Martin G. Pomper, Peter L. Choyke, Baris Turkbey
PSMA targeted radioligandtherapy in metastatic castration resistant prostate cancer after chemotherapy, abiraterone and/or enzalutamide. A retrospective analysis of overall survival
K. Rahbar, M. Boegemann, A. Yordanova, M. Eveslage, M. Schäfers, M. Essler, H. Ahmadzadehfar
Clinical performance of 68Ga-PSMA-11 PET/MRI for the detection of recurrent prostate cancer following radical prostatectomy
Benedikt Kranzbühler, Hannes Nagel, Anton S. Becker, Julian Müller, Martin Huellner, Paul Stolzmann, Urs Muehlematter, Matthias Guckenberger, Philipp A. Kaufmann, Daniel Eberli, Irene A. Burger
Targeted alpha therapy of mCRPC: Dosimetry estimate of 213Bismuth-PSMA-617
Clemens Kratochwil, Karl Schmidt, Ali Afshar-Oromieh, Frank Bruchertseifer, Hendrik Rathke, Alfred Morgenstern, Uwe Haberkorn, Frederik L. Giesel
Improving quality of life in patients with pancreatic neuroendocrine tumor following peptide receptor radionuclide therapy assessed by EORTC QLQ-C30
Milka Marinova, Martin Mücke, Lukas Mahlberg, Markus Essler, Henning Cuhls, Lukas Radbruch, Rupert Conrad, Hojjat Ahmadzadehfar
Prognostic value of lymph node-to-primary tumor standardized uptake value ratio in endometrioid endometrial carcinoma
Hyun Hoon Chung, Gi Jeong Cheon, Jae-Weon Kim, Noh-Hyun Park, Yong Sang Song
Metabolic activity by 18F–FDG-PET/CT is predictive of early response after nivolumab in previously treated NSCLC
Kyoichi Kaira, Tetsuya Higuchi, Ichiro Naruse, Yukiko Arisaka, Azusa Tokue, Bolag Altan, Satoshi Suda, Akira Mogi, Kimihiro Shimizu, Noriaki Sunaga, Takeshi Hisada, Shigehisa Kitano, Hideru Obinata, Takehiko Yokobori, Keita Mori, Masahiko Nishiyama, Yoshihito Tsushima, Takayuki Asao
Comparison of 18F-FDG PET/MRI and MRI for pre-therapeutic tumor staging of patients with primary cancer of the uterine cervix
Theresia Sarabhai, Benedikt M. Schaarschmidt, Axel Wetter, Julian Kirchner, Bahriye Aktas, Michael Forsting, Verena Ruhlmann, Ken Herrmann, Lale Umutlu, Johannes Grueneisen
18F–FDG PET/CT in solitary plasmacytoma: metabolic behavior and progression to multiple myeloma
Domenico Albano, Giovanni Bosio, Giorgio Treglia, Raffaele Giubbini, Francesco Bertagna
Diagnostic and prognostic value of 18F-FDG PET/CT in recurrent germinal tumor carcinoma
Pierpaolo Alongi, Laura Evangelista, Federico Caobelli, Marianna Spallino, Luigi Gianolli, Massimo Midiri, Maria Picchio
18F-FDG-PET detects complete response to PD1-therapy in melanoma patients two weeks after therapy start
Ferdinand Seith, Andrea Forschner, Holger Schmidt, Christina Pfannenberg, Brigitte Gückel, Konstantin Nikolaou, Christian la Fougère, Claus Garbe, Nina Schwenzer
Added diagnostic value of respiratory-gated 4D 18F–FDG PET/CT in the detection of liver lesions: a multicenter study
Cinzia Crivellaro, Elena De Ponti, Federica Elisei, Sabrina Morzenti, Maria Picchio, Valentino Bettinardi, Annibale Versari, Federica Fioroni, Miroslaw Dziuk, Konrad Tkaczewski, Renée Ahond-Vionnet, Guillaume Nodari, Sergio Todde, Claudio Landoni, Luca Guerra
89Zr-labeled nivolumab for imaging of T-cell infiltration in a humanized murine model of lung cancer
Christopher G. England, Dawei Jiang, Emily B. Ehlerding, Brian T. Rekoske, Paul A. Ellison, Reinier Hernandez, Todd E. Barnhart, Douglas G. McNeel, Peng Huang, Weibo Cai
Targeting angiogenesis for radioimmunotherapy with a 177Lu-labeled antibody
Emily B. Ehlerding, Saige Lacognata, Dawei Jiang, Carolina A. Ferreira, Shreya Goel, Reinier Hernandez, Justin J. Jeffery, Charles P. Theuer, Weibo Cai
PET and SPECT imaging of melanoma: the state of the art
Weijun Wei, Emily B. Ehlerding, Xiaoli Lan, Quanyong Luo, Weibo Cai
Comment on “Comparison of CT and PET/CT for biopsy guidance in oncological patients”
Long Chen, Hua Sun
From fixed activities to personalized treatments in radionuclide therapy: lost in translation?
G. D. Flux, K. Sjogreen Gleisner, C. Chiesa, M. Lassmann, N. Chouin, J. Gear, M. Bardiès, S. Walrand, K. Bacher, U. Eberlein, M. Ljungberg, L. Strigari, E. Visser, M. W. Konijnenberg
EANM Springer Prizes awarded at EANM’ 17 Vienna
Francesco Collamati, supervised by Riccardo Faccini: An intraoperative beta-probe for cancer surgery, Springer Theses
Gianluca De Matteis, Luigi Mansi
E. Edmund Kim, Hyung-Jun Im, Dong Soo Lee, Keon Wook Kang: Atlas and Anatomy of PET/MRI, PET/CT and SPECT/CT
Giuseppe Danilo Di Stasio, Luigi Mansi